PharmaPlot

PharmaPlot is a privately owned company established in 2016 with its headquarters in Greece. The company's motto, "Bridging data to compile unique products," emphasizes its commitment to developing, out-licensing, and supplying high-quality generic pharmaceutical products and value-added medicines. PharmaPlot offers a robust supply chain and a comprehensive range of services that encompass all stages of the pharmaceutical value chain, including product development, regulatory approval, and life cycle management. The company's portfolio comprises value-added solid dosage forms such as tablets and capsules, along with injectables, oral solutions, and suspensions, as well as generics suitable for Day 1 launch upon patent expiry. PharmaPlot's mission aligns with the advancement of science, technology, and regulation in the pharmaceutical industry, aiming to provide high-quality standard medicines to pharmaceutical companies worldwide through a robust supply chain. Although the last investment information and associated investors are currently unavailable, the company's focus on comprehensive pharmaceutical solutions and commitment to quality standards presents an intriguing opportunity in the pharmaceutical market. With its specialization in high-quality generic pharmaceutical products and value-added medicines, PharmaPlot has the potential to make a significant impact in the global pharmaceutical industry.